Central team in Kashmir to probe infant deaths

Image
IANS Srinagar
Last Updated : Oct 13 2013 | 1:25 PM IST

A five-member union Health Ministry team has arrived here to assist investigations into the death of eight infants, allegedly after administration of pentavalent vaccine, officials said Sunday.

The team of paediatricians, headed by Dr. N.K. Arora, arrived here Saturday on a three- day visit.

Dr. Muneer Masoodi of Srinagar's G.B. Pant hospital said the team would assist investigations into the death of infants following administration of the vaccine given to protect infants from hepatitis-B, diphtheria, tetanus, pertussis and Hib (haemophilus influenzae type-b).

Eight infants died in the Kashmir valley last week allegedly following administration of pentavalent vaccine in various hospitals.

Masoodi told IANS that two infants died Oct 10 after being given the vaccine. Six infants allegedly collapsed after the vaccination was administered to them in various district hospitals.

"The infants developed vomiting and severe allergic reaction which are very difficult to control after administration of pentavalent vaccine," he said.

The local doctors association has demanded a ban on pentavalent vaccine in the state, but it can only be done through an order of the union health and family welfare department, said the doctor.

Pentavalent vaccine, also known as Easy-Five, is given to protect infants from hepatitis-B, diphtheria, tetanus, pertussis and Hib (haemophilus influenzae type-b).

Baldev Sharma, director family welfare Jammu and Kashmir said that since the launch of the pentavalent vaccine in the state many vials of the vaccine had been administered to children for protection from these diseases, but no adverse reactions was reported till now.

The director said a detailed investigation has been ordered into these allegations and the probe would be completed within one week.

No decision could be taken on banning the vaccine till the completion of probe, said Sharma.

Parents have been agitating following the death of the infants.

"I will not take my daughter for any vaccination unless the controversy is resolved," said Bashir Ahmad, father of a two-year-old.

Official sources said the pentavalent vaccine was first introduced in December 2011 in Tamil Nadu and Kerala and later in Jammu and Kashmir, Goa, Gujarat, Haryana, Pondicherry and Karnataka.

Pentavalent vaccine was introduced to replace the traditional DPT vaccine administered to infants as protection against diphtheria, pertussis and tetanus.

According to a PIL filed in the Supreme Court against the use of the vaccine, the pentavelent vaccine has been banned or was not being used in European countries, Japan, the UK, Canada, and the US.

The PIL also said that Pakistan, Vietnam, Bhutan, and Sri Lanka have stopped using the vaccine after reports of serious allergic reactions and even deaths.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 13 2013 | 1:20 PM IST

Next Story